Cargando…
Clues to primary vismodegib resistance lie in histology and genetics
Basal cell carcinoma (BCC) is the most common human malignant neoplasm. However, there are multiple BCC subtypes that share clinical features while demanding different management. We present a case of a woman with hundreds of BCCs throughout her body that were resistant to vismodegib and without oth...
Autores principales: | Sun, Qisi, Atzmony, Lihi, Zaki, Theodore, Peng, Albert, Sugarman, Jeffrey, Choate, Keith A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513245/ https://www.ncbi.nlm.nih.gov/pubmed/32217615 http://dx.doi.org/10.1136/jclinpath-2020-206448 |
Ejemplares similares
-
Two percent lovastatin ointment as a pathogenesis-directed monotherapy for porokeratosis
por: Ugwu, Nelson, et al.
Publicado: (2020) -
Vismodegib: the Proof of Concept in Basal Cell Carcinoma
por: Berrada, Narjiss, et al.
Publicado: (2014) -
Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance
por: Gampala, Silpa, et al.
Publicado: (2021) -
Cutaneous and hepatic vascular lesions due to a recurrent somatic GJA4 mutation reveal a pathway for vascular malformation
por: Ugwu, Nelson, et al.
Publicado: (2021) -
Recent advances in understanding inherited disorders of keratinization
por: Zaki, Theodore, et al.
Publicado: (2018)